Prescribing factors influencing hospital length of stay in patients initiating lithium therapy for acute bipolar or schizoaffective mood episodes [0.03%]
锂治疗急性双相或分裂情感障碍情绪发作患者的用药因素对住院时长的影响分析
William G Cordell,Claire Herbst,Taylor Kelsey et al.
William G Cordell et al.
Introduction: Lithium has long been considered the gold standard mood stabilizer in the treatment of acute mood episodes related to bipolar (BD) and schizoaffective disorder. Previous research has primarily focused on lit...
Case report: Acamprosate for treatment of volatile hydrocarbon (VHC) inhalant use disorder with comorbid alcohol use disorder [0.03%]
个例报告：对于联同酒精使用障碍共病挥发性烃（VHC）吸入物使用障碍的治疗使用乙酰半胱氨酸的效果
Nariman Piri,Wesley Campbell
Nariman Piri
Introduction: Inhalant use disorder is a substance use disorder that involves the inhalation of volatile hydrocarbons (VHCs) to experience intoxication. Despite its prevalence and potential for adverse events, pharmacothe...
Impact of a psychiatric pharmacist on an inpatient psychiatry consultation liaison service [0.03%]
精神病药剂师对住院精神病咨询联络服务的影响
Harrison Ferro,Jennifer Dress
Harrison Ferro
Introduction: Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health treatment. Board Certified Psychiatric Pharmacist (BCPPs) are those who have demonstrated their level of exp...
Board-certified psychiatric pharmacists in substance use disorder treatment: Integration, services, and outcomes across care settings [0.03%]
物质使用障碍治疗中的认证精神病药剂师：跨护理设置的整合、服务和结果
Anuja Vallabh,Audrey Abelleira,Amber R Douglass et al.
Anuja Vallabh et al.
Introduction: At present, there is a shortage of clinicians providing substance use disorder (SUD) treatment, thereby limiting access to evidence-based care. Board-certified psychiatric pharmacists (BCPPs) are doctorate-l...
The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID [0.03%]
低剂量纳洛酮在临床上的应用潜力及其对长期新冠肺炎的关注重点
Sara L Pucci,Allison Veide,Haley Pierce et al.
Sara L Pucci et al.
Survey of local patterns of fentanyl exposure and harm reduction strategies in the Southeastern United States [0.03%]
美国东南部芬太尼暴露的地区特征及危害减少策略调查
Kaitlyn E Tenn,Sophie Robert,Brianne Mosley et al.
Kaitlyn E Tenn et al.
Introduction: Fentanyl, a synthetic opioid, is frequently found as a contaminant in illicit substances, significantly increasing overdose risk. A growing trend toward intentional fentanyl use further complicates the opioi...
Failed transition to buprenorphine extended-release injection from high-dose methadone [0.03%]
从高剂量美沙酮转换为布施龙长效注射液失败
Archana Jhawar,Shannon Menard-Okoroike
Archana Jhawar
Symptoms of opioid withdrawal with buprenorphine inductions pose significant challenges when trying to transition a patient from a full agonist opioid. There are numerous strategies to reduce the risk including traditional induction, microd...
Changes in PHQ-9 score after clinical pharmacy practitioner intervention in primary care mental health integration clinic [0.03%]
临床药学实践者干预对综合门诊患者PHQ-9量表评分变化的影响研究
Jessie Gant,Dillon Perryman,Stephanie Coveart
Jessie Gant
Introduction: The Lt. Col. Luke Weathers, Jr. Veterans Affairs Medical Center (Memphis VAMC) expanded clinical pharmacy mental health services to Primary Care Mental Health Integration (PCMHI) in July 2023. This expansion...
Changes in student pharmacists' self-perceived knowledge and confidence regarding suicide prevention as the result of instruction and training [0.03%]
实习药剂师自杀预防知识和信心的变化及教学和培训的结果
Jennifer W Beall,Marshall E Cates,Wendy Serrano et al.
Jennifer W Beall et al.
Introduction: Trained pharmacists could play a key role in suicide prevention. Suicide prevention programs for pharmacists and students have been described in published literature. This study aimed to determine the effect...
Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case report [0.03%]
与CYP2C19不良代谢相关的舍曲林戒断综合征和血清素毒性的一例报告
Elizabeth H Tran,Jeffrey R Bishop,Jacob T Brown et al.
Elizabeth H Tran et al.
Serotonin-related adverse drug reactions (ADRs) of selective serotonin reuptake inhibitors, including serotonin toxicity (ST) and antidepressant discontinuation syndrome (ADS), may significantly affect adherence to antidepressant therapy. S...